Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
Completed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2
2002-07-01
The purpose of this study is to study the effects of tolvaptan on the size and function of
the left heart chamber (ventricle) in patients with congestive heart failure (CHF)
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
Completed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2
2002-05-01
Patients with congestive heart failure will be assessed for safety and clinical effects of
Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
Completed
Otsuka Pharmaceutical Co., Ltd.
Phase 3
2003-04-01
This study's purpose is to determine whether tolvaptan can safely and effectively return the
body's balance of sodium and water toward normal, and to characterize and quantify the
potential clinical benefits of this treatment.
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
Completed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
2003-04-01
This study's purpose is to determine whether tolvaptan can safely and effectively return the
body's balance of sodium and water toward normal, and to characterize and quantify the
potential clinical benefits of this treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
